NCT01865799View on ClinicalTrials.gov

A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USA

CompletedOBSERVATIONAL

Enrollment

64,186

Participants

Timeline

Start Date

April 22, 2013

Primary Completion Date

January 22, 2018

Study Completion Date

January 22, 2018

Conditions

Pre-exposure Prophylaxis for Prevention of HIV Infection

Trial Locations (1)

94404

Gilead Sciences, Inc., Foster City

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY

NCT01865799 - A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USA | Biotech Hunter | Biotech Hunter